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Abstract: Background: Intimate partner violence (IPV) is a public health concern, especially during
pregnancy, and needs to be urgently addressed. In order to establish effective actions for the
prevention of IPV during pregnancy, authorities must be aware of the real burden of IPV. This review
aimed to summarize the existing evidence about IPV prevalence during pregnancy worldwide.
Methods: A review of reviews was carried out. All published systematic reviews and meta-analyses
published until October 2020 were identified through PubMed, Scopus, and Web of Science. The main
outcome was the IPV prevalence during pregnancy. Results: A total of 12 systematic reviews were
included in the review, 5 of them including meta-analysis. The quality of the reviews was variable.
Physical IPV during pregnancy showed a wide range (1.6–78%), as did psychological IPV (1.8–67.4%).
Conclusions: Available data about IPV prevalence during pregnancy were of low quality and showed
high figures for physical and psychological IPV. The existing evidence syntheses do not capture the
totality of the worldwide disease burden of IPV in pregnancy.
Keywords: intimate partner violence; pregnancy; prevalence; umbrella review
1. Introduction
Intimate partner violence (IPV), defined as physical violence, sexual violence, harassment,
and psychological assault (including coercive tactics) by a current or former intimate part-
ner [1], is a public health concern that urgently needs to be addressed. During pregnancy,
the woman experiences a situation of special dependence, both physical and emotional.
In this period, exposure to violence affects not only the mother but also the fetus, which is at
greater risk than in other stages of life [2]. In fact, IPV has been associated with adverse preg-
nancy outcomes including increased risk of human immunodeficiency virus infection [3],
perinatal depression [4], insufficient weight gain during pregnancy [5], uterine rupture,
hemorrhage, maternal death [6], prematurity, low birth weight, newborns small for ges-
tational age [7], stillbirth [8], and reduced levels of breastfeeding [9]. At the same time,
routine contacts with the health system offer an excellent detection window to identify
it and establish protective measures. Despite this, IPV during pregnancy is a neglected
condition, even though it is more common than many maternal health conditions like
preeclampsia and gestational diabetes [10].
IPV during pregnancy should be an avoidable global public health problem. However,
in order to establish effective actions for the prevention of IPV during pregnancy, such as
the performance of systematic screening and diagnosis of IPV in the antenatal visits,
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authorities must be aware of the real worldwide burden of IPV. However, information
about IPV prevalence is not consistent. Whereas some studies indicate higher prevalence of
IPV during pregnancy than before [11] or after [12,13] the pregnancy, other studies report
a smaller prevalence [14,15]. Furthermore, the prevalence of IPV during pregnancy is
reported to vary depending on the definition used [1], the screening strategy [16,17], and the
development status of the population studied [10,18]. These factors make comparison
between individually reported rates difficult.
This review aims to summarize the existing evidence about IPV prevalence dur-
ing pregnancy worldwide through a synthesis of systematic reviews and meta-analysis.
Prevalence studies provide a snapshot of a situation in a specific context, so it is important
to bring together different existing studies for a global understanding. This work analyzes
the existing reviews, identifying their strengths and limitations and laying the foundations
for future reviews that clarify the situation of IPV during pregnancy in a complete and
realistic way.
2. Materials and Methods
This umbrella review was written according to the Preferred Reporting Items for
Systematic Reviews and Meta-Analyses (PRISMA) statement for systematic reviews and
meta-analyses [19] and the Aromataris’ guidelines for performing umbrella reviews [20].
2.1. Inclusion and Exclusion Criteria
Systematic reviews and meta-analyses including observational studies reporting IVP
prevalence suffered by women during pregnancy were considered in this review. The types
of IPV were classified as physical, sexual, psychological and any type of IPV. Studies not
following a systematic review approach, narrative reviews, and primary studies were
excluded. No language restrictions were applied in this review.
2.2. Literature Search and Selection of Studies
Relevant systematic reviews and meta-analyses according to inclusion criteria were
identified through systematic searches of the following electronic databases: PubMed,
Web of Science and Scopus, CYNAHL, PsycINFO, Social Science Database, and Sociologi-
cal Abstracts. The full search strings can be found in Table 1. When the search engine used
only allowed selecting systematic reviews or meta-analyses, the terms “systematic reviews”
OR “meta-analyses” were not included in the search string; otherwise, those terms were in-
cluded. Studies published from inception until October 2020 were included. Reference lists
of identified studies were checked.
Table 1. Search strings.
Database Searching String
PUBMED
(“Intimate Partner Violence” [Mesh]) AND ((“Pregnancy” [Mesh])
OR (“Pregnant Women” [Mesh]) OR (“Prenatal Care” [Mesh]))
AND (“Prevalence” [Mesh])
Rest of databases (“Intimate Partner Violence”) AND ((“Pregnancy”) OR(“Pregnant Women”) OR (“Prenatal Care”)) AND (“Prevalence”)
2.3. Data Collection and Analysis
Eligible studies were selected through a multistep approach (elimination of duplicates,
title reading, abstract and full-text assessment). Two researchers (S.M.-P. and R.M.R.-G.)
independently examined titles and abstracts, evaluating afterwards full texts according
to the inclusion criteria described above. Any disagreement between the reviewers was
resolved by means of a consensus session with a third reviewer (A.B.-C.). In case of
ambiguity in reporting or lack of data, primary authors were contacted for clarification.
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2.4. Data Extraction and Management
Data were independently extracted by two researchers (S.M.-P. and R.M.R.-G.), and the
following information was considered for each article: (1) first author and year of pub-
lication; (2) interval of time covered by the review; (3) countries (of studies included in
the systematic review or meta-analysis); (4) number of studies included; (5) study design
(of studies included in the systematic review or meta-analysis); (6) sample characteristics;
(7) IPV as main outcome; (8) type of IPV investigated; (9) meta-analysis performance;
(10) IPV outcome.
2.5. Quality Assessment Tools
The updated AMSTAR 2 version for systematic reviews and meta-analyses was used
to evaluate the methodological quality and risk of bias of studies included in the systematic
review [21]. The overall final rating of each systematic review was judged as high, moderate,
low, or critically low. In case of disagreements, a consensus session with the third reviewer
(A.B.-C.) was held.
3. Results
The electronic search initially resulted in 199 citations. A total of 80 studies were
excluded after elimination of duplicates. From the 119 remaining, 61 were excluded after
title and abstract screening and 58 full-text articles were selected and read. From those,
a total of 12 systematic reviews were included in this umbrella review, of which 5 were
meta-analyses. The reasons for exclusion were the lack of data about IPV prevalence during
pregnancy (20), the use of violence other than IPV or the indistinct report of IPV or domestic
violence (10), investigations on populations with a specific risk, supposedly different from
the general population (12), and not being a systematic review or meta-analysis (4). The list
of the excluded articles is presented in Supplementary Materials Table S1. Figure 1 shows
the PRISMA flowchart and the study selection process.
Characteristics of included systematic reviews and meta-analyses are shown in Table 2.
Only two reviews included global data [22,23], most of which were limited to a country
or a group of countries, mainly from Asia [4,23–28] and Africa [4,26,27,29,30], followed by
America [31,32], Europe [32], and Australia [32]. The number of studies included in the
reviews giving information about IPV prevalence during pregnancy ranged from 2 [24] to
73 [23].
Most of the studies included in the selected reviews were cross-over studies, in which
there was only a single evaluation of the women sometime during pregnancy. Some of
the reviews also included cohort studies [4,24,25,30–32]. Reviews included studies giving
information about IPV only at pregnancy [22–24,27,29,30], both during pregnancy or at
postpartum [4,30–32], during pregnancy, or having a child 2 years old or younger [25] or at
current pregnancy or any pregnancy [26].
Wide differences were also observed regarding the type of IPV violence investigated.
Of the selected reviews, nine investigated prevalence of physical violence [4,22,24–28,30,31],
nine psychological violence [4,22,24–28,30,31], ten sexual violence [4,22–28,30,31], and three
any type of violence [26,29,32]. From the selected studies, four did not report IPV pregnancy
during pregnancy as main outcome [24–26,32]. Five studies showed a summarized estimate
of IPV during pregnancy [23,24,28–30]. In most of the reviews ranges of IPV prevalence
are given [4,22,24,26,27,31,32].
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Figure 1. PRISMA flowchart of the study selection process. 
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From the reviews included in the study, many showed data about any IPV prevalence
worldwide. The data about prevalence of any kind of IPV during pregnancy were obtained
from different countries [26,29,32]. The highest range of any IPV prevalence was obtained
in Portugal, USA, and Australia [32] (15.4–40%), followed by Ethiopia [29] (26.1% (95% CI:
20–32.3)) an countri from the Arab League [26] (40.9–44.1%).
Regarding physical IPV during pregnancy, China [28] and Vietnam [25] showed
the lowest ranges; (3.6% (95% CI: 1.6–6.2%)) and (3–8.5%) respectively. Higher ranges
were found in countries from Latin America [31] (2.5–38.7%), Africa and Asia [4] (2–35%)
followed by low- and middle-inco e countries [27] (5–52.8%), countries from the Arab
League [26] (10.4–34.6%) and African countries [30] (22.5–40%), being the widest range the
one found in Saudi Arabia [24] (21–78%). James and colleagues [22] showed a prevalence
of 13.8% in all over the world.
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As for any and physical IPV, China [28] showed the lowest and smallest ranges of
psychological IPV prevalence during pregnancy (4.2% (95% CI: 1.8–7.5%)). Higher ranges
were found in Vietnam [25] (6–32.5%) and countries from the Arab League [26] (23.4–
32.6%), Latin America [31] (13–44%), and African countries [30] (24.8–49%). The widest
ranges were found in low- and middle-income countries [27] (17–67.4%) and countries
from Asia and Africa [4] (22–65%). James and colleagues [22] showed a prevalence of 28.4%
throughout the world.
In general, sexual violence showed lower ranges of prevalence than the other types of
IPV violence during pregnancy, being the lowest in China [28] (1.3% (95% CI: 0.6–2.5%)),
followed by Vietnam [25] (3.4–10%), countries from the Arab League [26] (5.7–15.0%),
low- and middle-income countries [27] (2.8–21%), Africa [30] (2.7–26.5%) and Latin Amer-
ica [31] (3–34.4%). The highest and widest ranges of sexual IPV prevalence during preg-
nancy were found in countries from Asia and Africa in the study of Halim and colleagues [4]
(9–40%). Worldwide, prevalence of sexual IPV during pregnancy remained lower than
18% [22,23].
Quality assessment is reported in Table 3. Although all of the studies used a com-
prehensive literature search strategy, only two of the selected reviews did not include
the components of PICO in their research questions and inclusion criteria [22,24], the re-
views described the included studies in adequate detail, with the exception of three stud-
ies [22,26,32], and in only three of the reviews [22,25,27], authors did not report any
statement about potential sources of conflict of interest. For some other aspects of the
AMSTAR2 checklist, the quality remained low. Thus, none of the reviews included an
explicit statement that the review methods were established prior to the conduct of the
review nor the sources of funding for the studies included. Only one review provided
a list of excluded studies and justified the exclusions [28]. Only three of the reviews ex-
plained their selection of the study design for inclusion in the review [24–26]. Half of
the reviews performed study selection in duplicate [4,23–26,28], whereas only three did
not perform data extraction in duplicate [4,22,31]. Half of the studies included did not
use a satisfactory technique for assessing the risk of bias in individuals included in the
review [22,23,27,29,31,32], and more than half did not account for risk of bias in individual
studies when interpreting/discussing the results of the review [22–25,31–33]. Only two
of the reviews provided a satisfactory explanation for, and discussion of, any hetero-
geneity observed in the results of the review [22,26]. In the reviews where meta-analysis
was performed, the authors used appropriate methods for statistical combination of re-
sults [23,25,28–30], but in only three of them, the review authors assessed the potential
impact of risk of bias in individual studies [25,28,30] and only two [28,29] carried out an
adequate investigation of publication bias.
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Table 3. Evaluation of selected IPV during pregnancy reviews based on AMSTAR 2 guidelines.
AMSTAR 2 Checklist Items *
Author, Year 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16
Alebel et al., 2018 [29] Y N N Y N Y N Y N N Y N Y N Y Y
Alhalal et al., 2019 [24] N N Y Y Y Y N Y Y N NA NA N N NA Y
Bazyar et al., 2018 [23] Y N N Y Y Y N Y N N Y N N N N Y
Do et al., 2019 [25] Y N Y Y Y Y N Y Y N Y Y N N N N
Elghossain, 2019 [26] Y N Y Y Y Y N N Y N NA NA Y Y NA Y
Han and Stewart, 2014 [31] Y N N Y N N N Y N N NA NA N N NA Y
Halim et al., 2018 [4] Y N N Y Y N N Y Y N NA NA Y N NA Y
James et al., 2013 [22] N N N Y N N N N N N NA NA N Y NA N
Méndez-Figueroa et al., 2013 [32] Y N N Y N Y N N N N NA NA N N NA Y
Shamu et al., 2011 [30] Y N N Y N Y N Y Y N Y Y N N N Y
Udmuangpia et al., 2020 [27] Y N N Y N Y N Y N N NA NA Y N NA N
Wang et al., 2017 [28] Y N N Y Y Y Y Y Y N Y Y Y N Y Y
* Each number corresponds with an AMSTAR 2 checklist item as follows: 1. Did the research questions and inclusion criteria for the
review include the components of PICO? 2. Did the report of the review contain an explicit statement that the review methods were
established prior to the conduct of the review and did the report justify any significant deviations from the protocol? 3. Did the review
authors explain their selection of the study designs for inclusion in the review? 4. Did the review authors use a comprehensive literature
search strategy? 5. Did the review authors perform study selection in duplicate? 6. Did the review authors perform data extraction in
duplicate? 7. Did the review authors provide a list of excluded studies and justify the exclusions? 8. Did the review authors describe
the included studies in adequate detail? 9. Did the review authors use a satisfactory technique for assessing the risk of bias (RoB) in
individual studies that were included in the review? 9. Did the review authors report on the sources of funding for the studies included in
the review? 10. If meta-analysis was performed did the review authors use appropriate methods for statistical combination of results?
11. If meta-analysis was performed, did the review authors assess the potential impact of RoB in individual studies on the results of the
meta-analysis or other evidence synthesis? 12. Did the review authors account for RoB in individual studies when interpreting/discussing
the results of the review? 13. Did the review authors provide a satisfactory explanation for, and discussion of, any heterogeneity observed
in the results of the review? 14. If they performed quantitative synthesis did the review authors carry out an adequate investigation of
publication bias (small study bias) and discuss its likely impact on the results of the review? 15. Did the review authors report any potential
sources of conflict of interest, including any funding they received for conducting the review? NA, Not applicable.
4. Discussion
The aim of this umbrella review was to provide a summary of the evidence currently
available on global IPV prevalence in women during pregnancy. Despite the fact that
the selected reviews were recent, they are of low quality as assessed against most of
the AMSTAR2 recommendations. There were only two reviews giving worldwide IPV
prevalence during pregnancy [22,23], both of them complying with less than half of the
AMSTAR2 criteria.
4.1. Limitations
We selected systematic reviews for prevalence of IPV in pregnancy, yet we obtained
very diverse data. In the reviews, sometimes the concepts of IPV and domestic violence
were mixed together. Most of the included studies were cross-sectional self-report surveys,
which may have been associated with inaccurate recall [24,28,31]. They did not always
specify the gestational time point of IPV evaluation. It was common to find a mix among
studies assessing IPV at any time of pregnancy or even after pregnancy. This is important
since data can vary depending on the gestational age when IPV is measured, antenatally or
after delivery. One review [4] also included studies that assessed violence for a period that
is inclusive of, but not exclusive to, pregnancy.
Some of the included reviews, in spite of being systematic reviews, showed possi-
ble bias in studies included for evidence synthesis. They generally failed to adequately
address the heterogeneity of results [22,28,32]. Others had a very narrow geographi-
cal coverage [24–26,29]. In addition, sample sizes of the included studies were gener-
ally small [29–31], and the use of standardized and validated IPV instruments was low.
Geographical coverage of the reviews selected was mainly focused on low-income coun-
tries, a fact that invites readers to infer that IPV is a problem exclusive of those countries,
which is far from the reality [34].
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The main strength is that we have conducted an umbrella review following up the
PRISMA and Aromataris’ guidelines. Our search has been exhaustive, collecting all kind
of IPV.
4.2. Implications
Whereas the consequences of IPV during pregnancy on the mother and on the newborn
are widely known [3–9], the frequency and types of IPV in that period are not fully char-
acterized. WHO recommendations on antenatal care for a positive pregnancy experience
advise considering clinical inquiry about the possibility of IPV at antenatal care visits when
assessing conditions that may be caused or complicated by IPV [35]. Other prenatal care
guidelines affirm that clinical practitioners should be aware of the possibility of IPV, but do
not include any specific recommendation related to the screening [36]. It is well known
that IPV is associated with adverse mental health and obstetrical health consequences for
the mother, fetus, and child, but women are reluctant to speak about this topic without a
previous inquiry [37]. The American College of Obstetricians and Gynecologists guidelines
recommend screening for IPV at the first prenatal visit, at least once per trimester, and at
the postpartum checkup [38]. However, the overall rate of screening asymptomatic women
is distressing [39]. Due to the high prevalence of this serious problem, estimated violence
during pregnancy ranges from 15 to 40.5% for any type of violence, figures higher than
those previously reported by Perttu et al. [40]; it is vital to have a correct estimation of its
magnitude. These evaluations are necessary to underscore the importance of systematic
screening: only when health staff are aware of the right prevalence and repercussion of IPV
will they be able to cope with the screening barriers and to identify the most vulnerable
populations by introducing screening programs in antenatal care.
Isolated prevalence studies may underestimate the true IPV prevalence due to barriers
to open disclosure. These barriers could vary in different cultures and religions; e.g.,
widespread social norms in some regions support husbands’ right to physically discipline
wives. Abused women often face high social, economic, and legal barriers to divorce,
a situation that is made worse by unresponsive law enforcement and health care institutions.
In this social context, women are often reluctant to report violence to authorities and
may hesitate to disclose violence to survey interviewers. In many societies, women are
also reluctant to report violence because they are ashamed of living under this kind
of relationship.
Summarizing the figures of IPV prevalence in pregnancy is needed to highlight the
public health importance of this problem, with rates in some studies reported to be over
50%. These figures point towards the need of systematic screening in pregnancy. How-
ever, the analysis of published IPV reviews showed weaknesses in the research available
on this topic. This umbrella review allows us to identify some methodological aspects
that should be addressed in future reviews, related to geographic scope, study selection,
and bias assessment.
5. Conclusions
Available data about IPV prevalence during pregnancy are of low quality. The existing
evidence syntheses do not capture the totality of the disease burden in IPV in pregnancy.
Despite there being wide variability in existing prevalence figures, it is worth noting that
no less than 1 out of 50, and as many as 1 out of 2 women, could be suffering physical
IPV in pregnancy. Psychological IPV violence is reported to be even more frequent in
the published reviews. The existing evidence syntheses do not capture the totality of the
worldwide disease burden of IPV in pregnancy.
Supplementary Materials: The following are available online at https://www.mdpi.com/1660-460
1/18/2/707/s1, Table S1: List of excluded articles.
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